Dr. Israa

Vasculitis

Definition & Scope

Vasculitis is the inflammation of blood vessels.

  • Can affect all blood vessels.
  • Mainly affects arteries.
  • Includes: Gland arteries, arterioles, capillaries, veins, and venules.

Pathogenesis

  1. Large and Medium Blood Vessels (Direct Injury):

    • Molecular mimicry: Immune system activation of CD4+ T-cells leads to direct injury of blood vessels.
    • Occurs in Rheumatic Fever, Multiple Sclerosis, and Vasculitis.
    • Example: A virus enters the blood vessel wall; the immune system attacks it. Proteins in the endothelium resemble viral antigens, causing the immune system to attack the endothelium itself.
  2. Indirect Injury (Neutrophil Interaction):

    • A conflict between immune components (plasma cells and neutrophils).
    • Antibodies against neutrophils are produced (e.g., immune cells recognize neutrophils as foreign and destroy them).
    • Content release: Proteases lead to damage of the blood vessel (primarily affects small vessels).
  3. Immune Complex Deposition:

    • Antigen-Antibody complexes deposit in blood vessel walls (another disease; SLE as an example).
    • Example: In SLE, if complexes are in high amounts and cannot be excreted by the kidney, they deposit in walls, activating the complement system and damaging the vessel.

Healing and Consequences

  • Damage to BV → Underlying collagen is exposed → Stimulates coagulation cascade → Activation of clotting factors.
  • Thrombosis → Target organ damage.
  • Healing by Fibrosis → Reduced diameter → Ischemia.

General Clinical Manifestations

Due to inflammation and the release of inflammatory cytokines (IL-1, TNF):

  • Cytokines go to the hypothalamus and elevate body temperature.
  • Fever, myalgia, arthralgia.
  • Systemic: Reduced appetite, loss of weight, fatigability.
  • Labs: High ESR and CRP.
  • Symptoms of organ ischemia.

Large Vessel Vasculitis (Elastic Arteries)

Temporal (Giant Cell) Arteritis

  • Pathogenesis: Usually direct injury via CD4+ activation against blood vessel components (elastic fibers) due to molecular mimicry.
  • Demographics: Elderly Caucasian females (Giant mother).
  • Histology: Giant Cell Arteritis involves tunica media granuloma, elastic lamina destruction, and thickening of the tunica intima CC wrong?.
  • Layers of BV:
    • Tunica intima
    • Tunica media
    • Tunica adventitia
  • Anatomy: Affects branches of the Carotid Artery:
    • External Carotid branches: Lingual, superior thyroid, ascending pharyngeal, facial, buccal, occipital, posterior auricular, maxillary, and superficial temporal.
  • Note: (e)

Clinical Manifestations

  • General: Fever, malaise, myalgia.
  • PMR: Often associated with Polymyalgia Rheumatica (generalized muscle pain).
  • Specific Symptoms (if left untreated):
    • Blindness: Due to decreased blood supply to the Ophthalmic Artery (branch of internal carotid).
    • Temporal Headache: Can feel the thickened temporal artery.
    • Jaw Claudication: When eating, muscles of mastication will not find blood, leading to ischemia of the muscles (supplied by Trigeminal Mandibular V3).

Management

  • Diagnosis: Biopsy. Take a 20mm sample because the involvement is patchy (Patory); a small sample might miss the lesion.
  • Treatment: High-dose Glucocorticoids.
    • CRITICAL: Give immediately if suspected, even before biopsy confirmation, to prevent blindness.

Takayasu Arteritis

  • Demographics: Young Japanese females.
  • Anatomy: Affects the Aorta and its branches (e.g., Subclavian artery → axillary → brachial).
  • Pathology: Transmural inflammation and granulomas in the subclavian artery that heal by fibrosis.
  • Clinical Features:
    • Pulseless Disease: Absent pulse; can’t feel pulse in rabal.
    • Unequal Pulses: A cause of unequal pulse.
    • Differential for Unequal Pulse: Trauma (most common), poor technique, or injury to artery during ABG healing by fibrosis.
  • Treatment: Corticosteroids.

Medium Vessel Vasculitis (Muscular Arteries)

Kawasaki Disease

  • Target: Coronary Artery.
  • Demographics: Babies and children younger than 4 years.
  • Clinical Manifestations:
    • Fever + Cervical Adenopathy.
    • Rash: Hands and feet (Hand-foot syndrome).
    • Mucocutaneous: Oral ulcers (Strawberry tongue), genital ulcers, erythema.
  • Imaging: Beading of coronary artery noticed during catheterization (other).
  • Cardiac Risk: Young patients presenting with chest pain or ST elevation on ECG without history of familial hyperlipidemia or CREM. Think of inflammation of coronaries caused by Kawasaki.

Management & Differential

  • Management: High-dose Aspirin (given if suspicion is high).
  • Risk: In the young, can cause Reye Syndrome.
  • Differential Diagnosis (DD):
    • Mononucleosis + HIV.
    • Hand-Foot-Mouth Syndrome (caused by Coxsackie virus).

Buerger’s Disease (Thromboangiitis Obliterans)

  • Demographics: Male smokers, usually above age 40.
  • Pathogenesis: Smoking causes changes in the endothelium, making it look foreign to immune cells.
  • Clinical Features:
    • Claudication, Raynaud phenomenon, and autoamputation of fingers (leads to if severe ischemia).
    • Note: Cessation of smoking decrease disease activity; delay deterioration of disease (about not stop it).
  • Anatomy: Most affected vessels include the femoral, popliteal, anterior tibial, and posterior tibial arteries.

Management

  • Primary: Smoking cessation.
  • Medical: Prostaglandins, Calcium Channel Blockers (CCB) (to cause vasodilation).
  • Endothelin Receptor Antagonists: Cause VD by inhibiting calcium entry to BV.
  • Contraindications: Beta-blockers (BB) are contraindicated because small vessels have B2 receptors that cause VD; blocking them causes VC, leading to more ischemia.

Polyarteritis Nodosa (PAN)

  • Pathology: Affects medium-sized muscular and elastic arteries.
  • Imaging: “String of Pearls” appearance.
  • Key Feature: Palpable purpura.
  • Sparing: Does NOT affect pulmonary vessels.
  • Associations: 30% of patients are positive for Hepatitis B.
  • Organ Involvement:
    • Kidney: Antigen-antibody complex deposits lead to renal failure (elevated creatinine).
    • Nervous System: Peripheral neuropathy (wrist drop, foot drop) due to affection of bvs supplying nerve.
    • CNS/Eyes: Ptosis, ophthalmoplegia, acuminatorn affection.
  • Necrosis: Can occur “everywhere” except the lungs.

Treatment

  • Corticosteroids: Note that long-term use can cause Cushing Syndrome.
  • Steroid-sparing agents: Methotrexate, Azathioprine, Cyclosporine.

Small Vessel Vasculitis

Granulomatosis with Polyangiitis (Wegener’s)

  • Antibody: C & C ANCA (antibody against PR3).
  • Clinical Triad (L-U-K):
    • L (Lower Respiratory): Hemoptysis.
    • U (Upper Respiratory): Sinusitis, Saddle-shape nose deformity.
    • K (Kidney involvement): Nephritis/Nephritic syndrome (Hematuria, HTN).

Microscopic Polyangiitis

  • Antibody: p-ANCA positive.
  • Differences from Wegener’s:
    • No Upper Respiratory involvement (no sinusitis, no saddle nose).
    • No Granulomas.
  • Similarities: Lower respiratory and Kidney involvement (Nephritic syndrome).

Churg-Strauss Syndrome (EGPA)

  • Antibody: p-ANCA positive.
  • Clinical Features (H-E-L-P):
    • H (Heart involvement): Pericarditis.
    • E (Eosinophilia).
    • L (Allergic): Asthma (leukotriene antagonist).
    • P (Peripheral Neuropathy).
  • Treatment: Corticosteroid.
  • Note: Rash is common with all small vessel diseases. (Handwritten note: “rash with all small vessel disease”).

Henoch-Schönlein Purpura (IgA Vasculitis)

  • Pathogenesis: Abnormal form of IgA. Often follows an Upper Respiratory Tract Infection (URTI) or Gastroenteritis (within 1 week).
  • Mechanism: IgA increases; IgG attacks the abnormal IgA (Antibody against Antibody). Deposits in blood vessels and kidneys.
  • Clinical Features (G-A-P):
    • G (Glomerulonephritis): Berger’s Disease (immune complex deposits).
    • A (Arthralgia): Joint pain.
    • P pANCA negative (Palpable Purpura): Found on eczensor surface of leg, extensor surface of back, and buttocks.
    • Complications: Intussusception, intestinal valvulosis, honaturia/hematuria, glomerulonephritis.
  • Antibody: p-ANCA negative.

Management & Differential

  • Treatment: Corticosteroids, Plasmapheresis, and Immunoglobulins (to clear IgA).
  • Differential (IgA in Kidney):
    • IgA Nephropathy: Disease only in kidney; presents 3-4 days after infection ((3 normal), deposit in mesangial cells).
    • Post-Streptococcal GN: Presents 2 weeks after infection; (3 low); humpY dumpy subepithelial deposits.

Gyoglobulinemia (Small BV Disease)

  • Association: Bassociated with Hepatitis C.

Behçet’s Disease

  • Scope: Affects all blood vessels (arteries and veins, capillaries). - presents with thromboosis
  • Clinical Features:
    • Oral and Genital Ulcers.
    • Anterior Uveitis.
    • Erythema Nodosum (on legs).
    • Arthralgia.
    • Complications: Widespread thrombosis and embolism.

THANK YOU!